arrow
N

Nadège Vimond

nantes université, chu nantes and inserm
H指数:17
被引数:2,333

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

First-in-class anti-human CD45RC antibody targets CD45RChigh T and B cells to mitigate pathogenic immune responses

First-in-class anti-human CD45RC antibody targets CD45RChigh T and B cells to mitigate pathogenic immune responses

2025-10-300
OAAI
IL-34 deficiency impairs FOXP3+ Treg function in a model of autoimmune colitis and decreases immune tolerance homeostasis

IL-34缺乏损害自身免疫性结肠炎模型中的FOXP3 Treg功能并降低免疫耐受稳态

2022-08-2810
OAAI
Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease
2020-06-0814
OAAI
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
2016-04-08642
OAAI
Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma

淋巴细胞中的趋化因子受体模式反映了黑色素瘤的转移扩散

2016-02-0864
OA
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25 (vol 25, pg 399, 2015)

CTLA-4阻断的抗癌免疫疗法: IL-2受体的强制性贡献和可溶性CD25的负面预后影响 (第25卷,399页,2015页)

2015-03-03149
OAAI
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
2015-01-13149
OAAI
Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors

免疫浸润是局部胃肠道间质瘤的预后因素

2013-06-13267
OA